Sincalide
Tests For Bile Duct Patency
Sold as KINEVAC
- Drug class
- Tests For Bile Duct Patency
- Availability
- Prescription only
- Routes
- Intravenous
- Markets covered
- 2
- Products on record
- 3
- FDA reports (12 mo)
- 3
Overview
Sincalide is an active pharmaceutical ingredient in the Tests For Bile Duct Patency group (V04CC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 2 | January 22, 2026 |
| US United States | FDA | 1 | October 18, 2023 |
CACanada· Health Canada
2 products
Uses
Kinevac (sincalide) is indicated for: • Inducing contraction of the gallbladder during cholecystography. In many instances, the cystic and common bile ducts can also be visualized, especially if viewed 1 to 3 minutes after injection of Kinevac (sincalide).
, to determine the degree of cholesterol saturation. , in suspected cancer of the pancreas. • The relief of postoperative ileus uncomplicated by inflammatory processes such as pancreatitis and peritonitis or by the presence of tumors or other obstructions in the lower digestive tract.
• Decreasing the small bowel transit time of contrast media. 1 Pediatrics Pediatrics (<18 years): The safety and efficacy of Kinevac in pediatric patients has not been established; therefore, Health Canada has not authorized an indication for pediatric use.
2 Geriatrics Geriatrics (>65 years of age): Clinical studies of Kinevac did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.
USUnited States· FDA
1 product
Uses
1 INDICATIONS AND USAGE Kinevac is indicated in adults to: to stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; to stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; to accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract.
Kinevac is a cholecystokinin (CCK) analog indicated in adults to: stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals.
( 1 ) stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology. ( 1 ) accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract.
Sources & citations
- [1]Health Canada (DPD) · 02228602 · revised March 22, 2025
- [2]FDA DailyMed · 1408aabb-6982-48… · revised October 18, 2023 [PDF]
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.